Skip to content

Azhinjil vithai kuzhi thailam for the management of Puzhuvettu in children

An open label pilot clinical trial to evaluate the effectiveness of Azhinjil vithai kuzhi thailam (internal and external) for the management of Puzhuvettu (Alopecia areata) in children - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086772
Enrollment
10
Registered
2025-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: AZHINJIL VITHAI KUZHI THAILAM: 5 to 7 years 100 mg (3 drops) (bd) 8 to 12 years 200 mg (6 drops) (bd) for 45 days Control Intervention1: NA: NA

Sponsors

National Institue of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are satisfying minimum of 3 to 4 symptoms Willing to take photographs whenever required Patients who are willing to stay in IPD Ward or willing to attend OP Dept as per schedule Patient informant or Parent willing to sign the informed consent SALT Score less than 75 percent

Exclusion criteria

Exclusion criteria: Alopecia universalis Alopecia totalis Vitiligo Tinea capitis Trichotillomania

Design outcomes

Primary

MeasureTime frame
Grade I Slight improvent upto 25% Grade II Moderately improvement 25 to 50% Grade III Obvious improvement 51 to 75 % Grade IV Marked improvement more than 75%Timepoint: Screening - 1 month Patient enrollment - 1 month trial drug - 2 month Data analysis - 1 month Follow up - 1

Secondary

MeasureTime frame
Assessment of remission of symptomsTimepoint: Screening - 1 month Patient enrollment - 1 month trial drug - 2 month Data analysis - 1 month Follow up - 1

Countries

India

Contacts

Public ContactDr A M Amala Hazel

National Institute of Siddha

dramalaaruldhas@gmail.com9486909809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026